Concepedia

Jay M. Matthews

JM

Statistics

Publications

15

Citations

435

H-Index

13

Active since

1997

Affiliations

Johnson & Johnson (United States)(Current)

Springhouse

GlaxoSmithKline (United States)

Janssen (United States)

Jay M. Matthews is an author at Johnson & Johnson (United States) specializing in medicinal chemistry, drug discovery, and pharmacology.

ORCID

Publications per year

1997–2022

15

Publications

15

Base-Promoted Solid-Phase Synthesis of Substituted Hydantoins and Thiohydantoins

Jay M. Matthews, Ralph A. Rivero · The Journal of Organic Chemistry · 1997 · 91 citations

, , +6

Solid-Phase Synthesis of Substituted Tetramic Acids

Jay M. Matthews, Ralph A. Rivero · The Journal of Organic Chemistry · 1998 · 36 citations

, , +6

Synthesis and biological evaluation of novel indoloazepine derivatives as non-peptide vasopressin V2 receptor antagonists

Jay M. Matthews, Michael N. Greco, Leonard R. Hecker et al. · Bioorganic & Medicinal Chemistry Letters · 2003 · 36 citations · Full text

, , +8

The design and synthesis of novel, phosphonate-containing transient receptor potential melastatin 8 (TRPM8) antagonists

Jay M. Matthews, Raymond W. Colburn, Scott L. Dax et al. · Bioorganic & Medicinal Chemistry Letters · 2012 · 35 citations · Full text

, , +10

Design and Optimization of Sulfone Pyrrolidine Sulfonamide Antagonists of Transient Receptor Potential Vanilloid-4 with in Vivo Activity in a Pulmonary Edema Model

Joseph E. Pero, Jay M. Matthews, David J. Behm et al. · Journal of Medicinal Chemistry · 2018 · 34 citations · Full text

, , +17

1–5 of 15